Home - Products - Autophagy - CXCR - CXCR7 antagonist-1

CXCR7 antagonist-1

CAS No. 1613021-99-0

CXCR7 antagonist-1( —— )

Catalog No. M35092 CAS No. 1613021-99-0

CXCR7 antagonist-1 is a specific antagonist of the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CXCR7.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	454	In Stock
10MG	655	In Stock
25MG	1026	In Stock
50MG	1376	In Stock
100MG	1823	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CXCR7 antagonist-1
Note

Research use only, not for human use.
Brief Description

CXCR7 antagonist-1 is a specific antagonist of the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CXCR7.
Description

CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Autophagy
Target

CXCR
Recptor

CXCR
Research Area

——
Indication

——

Chemical Information

CAS Number

1613021-99-0
Formula Weight

390.41
Molecular Formula

C21H19FN6O
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (256.14 mM; Ultrasonic )
SMILES

Fc1ccc(cc1)-n1ccc(n1)C(=O)N[C@H]1CCN(C1)c1nccn2cccc12
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

USL311

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
AMD 3465 hexahydrobr...

AMD 3465 hexahydrobromide is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity.
CTCE 9908

CXCR4 antagonist; induces mitotic catastrophe in ovarian cancer cells. Displays additive cytotoxic effects when given with taxol. Enhances the efficacy of docetaxel in a mouse model.

Sign In Join Free